TC
ALAB icon

Trilogy Capital’s Astera Labs ALAB Stock Holding History

Trilogy Capital’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Sell
2,750
-3,850
-58% -$1.02M 0.05% 182
2026
Q1 		$723K Buy
6,600
+1,249
+23% +$178K 0.03% 222
2025
Q4 		$890K Buy
5,351
+1,650
+45% +$276K 0.04% 199
2025
Q3 		$725K Sell
3,701
-399
-10% -$65.6K 0.03% 208
2025
Q2 		$371K Buy
+4,100
New +$324K 0.02% 268

Other funds holding ALAB

SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TEC
Tensor Edge Capital Weston, Massachusetts $1.51B AUM
MLCM
M & L Capital Management London, United Kingdom $370M AUM 165.61% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
GXJ
Global X Japan Chiyoda-Ku, Tokyo, Japan $2.72B AUM 45.88% 1-Year Est. Return
IFS
Integrated Financial Solutions Reston, Virginia $185M AUM 67.6% 1-Year Est. Return

Trilogy Capital's ALAB Position: Q2 2026 in Review

Trilogy Capital reduced its Astera Labs (ALAB) stake by 58% in Q2 2026, selling an estimated $1.02M and leaving 2,750 shares worth $1.33M. The position accounts for 0.05% of the portfolio, ranked #182.

Trilogy Capital first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 107 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Trilogy Capital held 2,750 shares of Astera Labs worth $1.33M as of Q2 2026.
  • Trilogy Capital sold 3,850 Astera Labs shares in Q2 2026, an estimated $1.02M.
  • Astera Labs made up 0.05% of Trilogy Capital's portfolio in Q2 2026, its #182 holding.
  • Trilogy Capital first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 107 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.